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Dconversion; (2) stages 1 and 2 combined (avoidance of shunt
physiology)24; (3) stages 1 to 3 combined (1-stage neonatal
Fontan repair). This technology applies to both a 3-way
‘‘T’’ (stage 2 Glenn; hemi-Fontan) and 4-way ‘‘t’’ (stage 3;
TCPC). As a platform device, asymmetric impeller or surface
(vane) modification can address differential inflow and
outflow rates. In adults, the majority of complications of
failing Fontan physiology arise from the IVC distribution,
which accounts for 70% of total systemic venous return.
Conversely, in neonates, upper-body venous return comprises
60% to 70% total venous flow, which is largely a reflection of
cerebral blood flow (90% SVC flow).25CONCLUSIONS
This report describes a de novo pump concept and its an-
atomic and physiologic limitations and constraints. Much
work remains to carry this concept to clinical implementa-
tion. A limitation of this preliminary analysis is that the
impeller tested was a rigid rather than an expandable proto-
type. Furthermore, the device was scaled to adult dimen-
sions; performance at dimensions suitable for infants and
neonates remains to be determined. Future investigation
will include reduced scale analyses, hydraulic optimization,
and hemolysis and thrombogenicity assessment. Shear stress
and hemolysis are not expected to be problems given the
lower rotation requirements of this device in comparison
with commercially available microaxial devices. A viscous
impeller pump makes mechanical circulatory support of
a univentricular Fontan circulation a more realistic consider-
ation. Proven safe and effective, a viscous impeller pump
will greatly improve therapy for individuals with single-
ventricle heart disease.References
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Dr Glen Van Arsdell (Toronto, Ontario, Canada). With this
presentation, Dr Rodefeld and his colleagues have introduced an
important conceptual leap around the ideas for mechanical assist
in single-ventricle palliation. This is the first time one can actually
envision one of the holy grails for single-ventricle surgery, ie,
1-stage neonatal Fontan with outcomes that match neonatal biven-
tricular repair. Except for incremental improvements in single-
ventricle surgery, it appears to me that we have reached a ceiling.
Now we can see beyond that ceiling, at least conceptually. I have
3 questions for you. One, in your model, it appears that the study
is based on a rigid wall concept. In humans, there is some rigidity
and some flexibility in a standard Fontan setup. Can you talk with
us about how you envision dealing with this conceptually? I know
you mentioned the cage, but one of the issues with the microaxial
devices is wall trauma and cavitation.rdiovascular Surgery c Volume 140, Number 3 535
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DDr Rodefeld. What you are seeing is the first iteration of the
pump concept, and it is demonstrated in an idealized rigid conduit.
There are ways to model a compliant vessel, either by using a com-
putational technique or by in vitro modeling, and certainly those
would be done with additional studies, and very eloquent modeling
can account for vessel compliance in this situation.
DrVanArsdell. So do you have a sense of the ‘‘suction’’ effects
on the walls in this device as compared to a microaxial device?
DrRodefeld. I don’t have any hard data on it. This type of pump
is a slippery pump, it is a weak pump, and it is the reason why you
don’t see it used in a lot of industrial applications. But my sense is
that the negative pressure generation is going to be much less of
a problem than what you would see with a fixed radius, microaxial
flow pump that has to spin at high speed.
Dr Van Arsdell. Second, many of the patients that may poten-
tially benefit from this are our current failing Fontan population,
which is primarily an atriopulmonary connection type of arrange-
ment. Would you envision this usage in that connection or would it
require a conversion to the present extracardiac Fontan arrangement?
DrRodefeld. This particular device would not apply necessarily
for an atriopulmonary type of construction. The field has moved
away from that, but obviously the older failing Fontan patients
that we are dealing with presently had the prior atriopulmonary
type of reconstruction. I think at this point I would advocate conver-
sion to a total cavopulmonary connection, which, as you know,536 The Journal of Thoracic and Cardiovascular Surggives the benefit of 2 to 5 mm Hg pressure streamlining, which ac-
tually supports this pump impeller concept as well, and then if they
need additional temporary support, this pump could provide that.
Dr Van Arsdell. It would seem to me one of the advantages of
this is that you might raise the margin of safety around Fontan con-
version to a more modern Fontan.
My final question: One of the most remarkable things in this pre-
sentation to me is the level of efficiency of flow seen with the static
implantation of a disk alone. Are you looking at or should we be
looking at a biologically compatible disk that could be suspended
magnetically within the current Fontan arrangement, ie, implanted
at the time of Fontan or that could be implanted percutaneously
later?
Dr Rodefeld. This could be potentially placed as a static device
percutaneously, similar to a venocaval filter type of deployment or
retrieval strategy. There are other groups that have talked about
a static device in the cavopulmonary connection. Most important
would be the Georgia Tech group and Ajit Yoganthan have re-
ported on a flow splitting device that would optimize streamlining
through the cavopulmonary connection. This could be considered
as a static device, but the pressure reduction is fairly small. So
whether that would have a clinical impact or not, I am not sure at
this point.
Dr Van Arsdell. Congratulations on this excellent manuscript.
Dr Rodefeld. Thank you.ery c September 2010
